Articles

Breast cancer treatments pose significant fertility risks, emphasizing the importance of fertility counseling and preservation techniques, as highlighted by a study on young breast cancer patients. Read More ›

Adding aromatase inhibitors to ovarian function suppression significantly improves invasive disease-free survival and underscores the importance of individualized treatment decisions based on clinicopathological factors. Read More ›

The incidence of breast cancer in young women has been increasing globally, and understanding its management and prognosis is crucial due to its aggressive nature and poor outcomes. Read More ›

Adjuvant treatment options for premenopausal women with hormone receptor–positive breast cancer now include endocrine therapy and ovarian function suppression (OFS) based on clinicopathologic characteristics that determine composite risk of recurrence. Read More ›

Understanding the role of the estrogen receptor (ER) in the pathogenesis of breast cancer has led to the development of treatment options that lead to reduced estrogen levels. In addition, the expression level of ER can serve as a prognostic indicator for disease recurrence and treatment response. Read More ›